Cough syrup deaths: India seeks details from Uzbekistan on investigations

Union Health Minister Mansukh Mandaviya said further action would be taken based on the inspection of the pharma company

India is in touch with the Uzbak authorities, and has sought details of their investigation into the death of 18 children after allegedly consuming cough syrup made by an Indian firm, the Ministry of External Affairs (MEA) said yesterday.

Arindam Bagchi, spokesperson, MEA, also said consular assistance is being provided to some linked to the company who are facing legal action there.

Noting that the Uzbek authorities have not formally taken up the matter with New Delhi, he said, “Nevertheless, our embassy has contacted the Uzbek side, and is seeking further details of their investigation … We understand that legal action has been initiated by the Uzbek authorities against some people, including the local representative of the company there.”

And, in that context, we are extending necessary consular assistance to those individuals or individual,” he said.

The comments came even as a probe has already been launched by the Central Drugs Standard Control Organization (CDSCO) in connection with the death of 18 children in Uzbekistan allegedly linked to the cough syrup, while the manufacturing of Marion Biotech’s Dok-1 Max has also been suspended.

Union Health  Minister Dr Mansukh Mandaviya also said further action would be taken based on the inspection of the pharma company.

Edits by EP News Bureau

CDSCODr Mansukh MandaviyaMinistry of External Affairspharma companies investigationUzbekistan cough syrup deaths
Comments (2)
Add Comment
  • soundos

    thanks for sharing such a nice information

  • djamila_st

    This article is an appealing wealth of informative data that is interesting and well-written. I commend your hard work on this and thank you for this information.